NCT05191017 2022-08-05Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPCNuvation Bio Inc.Phase 1/2 Withdrawn
NCT03325127 2018-10-31Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review StudyBayerWithdrawn